One-Shot treatment tested to control blood cancer without ongoing drugs
NCT ID NCT07333261
Summary
This early-stage study is testing a one-time treatment called BMS-986453, a type of CAR-T cell therapy, for people newly diagnosed with multiple myeloma who are not planning to have a stem cell transplant. The main goal is to see if this single treatment is safe and can help control the cancer for a long time, potentially replacing the need for continuous medication. The study will enroll about 25 participants to monitor their health, how well the cancer responds, and how long the treatment's effects last.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Alabama at Birmingham
RECRUITINGBirmingham, Alabama, 35294, United States
Contact
Contact
Contact
Contact Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.